SCHEMBL600527

SCHEMBL600527

OC(c1ccc2ccccc2c1)c1ccc2ccccc2c1

nearest known ligand 0.87

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
UGT2B7 P16662 1/20 0.68
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
ATM Q13315 1/20 0.57
SLC6A2 P23975 10/20 0.52
SLC6A4 P31645 10/20 0.52
SLC6A3 Q01959 10/20 0.52
KCNH2 Q12809 5/20 0.52
CYP2D6 P10635 2/20 0.52
CYP1A2 P05177 2/20 0.52
AOC3 Q16853 1/20 0.52
TSHR P16473 1/20 0.52
HIF1A Q16665 1/20 0.52
CYP3A4 P08684 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30033673 1.00 UGT2B7 (0.68) UGT2B7MEN1KMT2AATMSLC6A2
SCHEMBL477559 0.93 UGT2B7 (0.61) UGT2B7MEN1KMT2AATMSLC6A2
SCHEMBL477557 0.93 UGT2B7 (0.61) UGT2B7MEN1KMT2AATMSLC6A2
SCHEMBL30161628 0.93 UGT2B7 (0.61) UGT2B7MEN1KMT2AATMSLC6A2
SCHEMBL26326669 0.88 UGT2B7 (0.55) UGT2B7MEN1KMT2AATMSLC6A2
SCHEMBL26326654 0.88 UGT2B7 (0.60) UGT2B7MEN1KMT2AATMSLC6A2
SCHEMBL17230348 0.88 UGT2B7 (0.55) UGT2B7MEN1KMT2AATMSLC6A2
SCHEMBL26326655 0.88 UGT2B7 (0.55) UGT2B7MEN1KMT2AATMSLC6A2
SCHEMBL14033733 0.88 UGT2B7 (0.55) UGT2B7MEN1KMT2AATMSLC6A2
SCHEMBL12405817 0.87 UGT2B7 (0.53) UGT2B7MEN1KMT2AATMSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4735955-A2 SYSTEMS AND METHODS FOR GENERATING ENTANGLED PHOTONS NVision Imaging Technologies GmbH (DE) 2026-05-06 EP disclosed
WO-2025125907-A2 SYSTEMS AND METHODS FOR GENERATING ENTANGLED PHOTONS NVISION IMAGING TECHNOLOGIES GMBH (DE) 2025-06-19 WO disclosed
EP-4523152-A1 SYSTEMS AND METHODS FOR QUANTUM COMPUTING NVision Imaging Technologies GmbH (DE) 2025-03-19 EP disclosed
WO-2023218402-A1 SYSTEMS AND METHODS FOR QUANTUM COMPUTING NVISION IMAGING TECHNOLOGIES GMBH (DE) 2023-11-16 WO disclosed
US-11664093-B2 Extrapolative prediction of enantioselectivity enabled by computer-driven workflow, new molecular representations and machine learning THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2023-05-30 US disclosed
CN-112961183-B C3-phosphono substituted benzohydrofuran and benzofuran compounds and preparation method thereof 成都大学 2023-05-16 CN disclosed
CN-115651014-A Method for synthesizing diaryl phosphonate derivatives by acid catalysis 西北民族大学 2023-01-31 CN disclosed
US-10377848-B2 Aromatic resins for underlayers ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2019-08-13 US disclosed
EP-2251316-B1 METHOD FOR PRODUCING OPTICALLY ACTIVE ESTER AND METHOD FOR PRODUCING OPTICALLY ACTIVE CARBOXYLIC ACID TOKYO UNIV OF SCIENCE EDUCATIONAL FOUNDATION ADMINISTRATIVE ORGANIZATION (JP) 2018-02-21 EP disclosed
US-9636670-B2 Catalysts, ligands and use thereof OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2017-05-02 US disclosed
US-7714167-B2 Catalytic asymmetric epoxidation UNIVERSITY OF CHICAGO (US) 2010-05-11 US disclosed
US-7714167-B2 Catalytic asymmetric epoxidation UNIVERSITY OF CHICAGO (US) 2010-05-11 US disclosed
EP-1706205-B1 A CATALYTICAL ASYMMETRIC EPOXIDATION UNIV CHICAGO (US) 2008-10-29 EP disclosed
EP-1706205-B1 A CATALYTICAL ASYMMETRIC EPOXIDATION UNIV CHICAGO (US) 2008-10-29 EP disclosed
US-20070203347-A1 Catalytic asymmetric epoxidation THE UNIVERSITY OF CHICAGO (US) 2007-08-30 US disclosed
US-20070203347-A1 Catalytic asymmetric epoxidation THE UNIVERSITY OF CHICAGO (US) 2007-08-30 US disclosed
US-20070203347-A1 Catalytic asymmetric epoxidation THE UNIVERSITY OF CHICAGO (US) 2007-08-30 US disclosed
WO-2007086878-A2 COATING COMPOSITIONS CONTAINING SINGLE WALL CARBON NANOTUBES EASTMAN KODAK COMPANY (US) 2007-08-02 WO disclosed
US-7202371-B2 Catalytic asymmetric epoxidation THE UNIVERSITY OF CHICAGO (US) 2007-04-10 US disclosed
US-7202371-B2 Catalytic asymmetric epoxidation THE UNIVERSITY OF CHICAGO (US) 2007-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203347-A1 Catalytic asymmetric epoxidation DUOX1, DUOX2, EPHX2 UGT2B7 430/4885MEN1 4635/4885KMT2A 2010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.